HURA
TuHURA Biosciences, Inc./NV
Company overview
- Market capitalization
- $133.19M
- Employees
- 22
- Latest publication
- 2026-09-29
About TuHURA Biosciences, Inc./NV
TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company's lead product candidate includes IFx2.0, an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. It is also preparing to initiate a single randomized placebo-controlled which is in Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda; and Delta receptor technology to develop tumor microenvironment modulators in the form of first-in-class bi-functional and bi-specific antibody-drug conjugates targeting Myeloid Derived Suppressor Cells. In addition, the company is also developing Immune Fx; IFx-3.0, an mRNA innate immune agonist candidate for intravenous or autologous whole cell administration for blood-related cancers. The company was formerly known as Morphogenesis, Inc. and changed its name to TuHURA Biosciences, Inc. in December 2023. The company was founded in 1995 and is based in Tampa, Florida. TuHURA Biosciences, Inc. operates as a subsidiary of CohBar, Inc.
Financial statements
Income Quarterly
| Metric | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | — | 0USD | 0USD |
| Cost Of Revenue | 23,472USD | — | 21,000USD | — | 14,058USD | 17,635USD | 29,000USD | 17,000USD |
| Gross Profit | -23,472USD | — | -21,000USD | — | -14,058USD | -17,635USD | -29,000USD | -17,000USD |
| Research Development | 5,232,541USD | 6,055,466USD | 4,968,596USD | 4,926,936USD | 4,581,672USD | 3,976,470USD | 2,946,769USD | 101,000USD |
| Selling General Administrative | 2,297,358USD | 1,561,727USD | 1,761,007USD | 4,949,020USD | 2,435,351USD | — | 1,957,000USD | 795,660USD |
| Total Operating Expenses | 7,506,427USD | 8,173,357USD | 6,729,603USD | 9,875,956USD | 7,017,023USD | 5,677,151USD | 3,701,228USD | 2,368,000USD |
| Operating Income | -7,529,899USD | -8,173,357USD | -6,729,603USD | -9,875,956USD | -7,017,023USD | -5,694,786USD | -3,730,228USD | -2,385,000USD |
| Interest Income | 21,275USD | 609USD | 6,060USD | 29,466USD | 100,098USD | — | — | 58,040USD |
| Interest Expense | 27,974USD | 608,751USD | 16,532USD | 0USD | 0USD | 522,835USD | 2,002,886USD | 1,357,458USD |
| Net Interest Income | -6,699USD | -608,142USD | -10,472USD | 29,466USD | 100,098USD | — | 49,000USD | -1,299,418USD |
| Income Before Tax | -7,536,598USD | -6,761,316USD | -7,102,455USD | -9,523,835USD | -6,664,371USD | -5,995,811USD | -5,579,118USD | -2,324,000USD |
| Net Income | -7,536,598USD | -6,769,672USD | -7,102,455USD | -9,523,835USD | -6,664,371USD | -5,995,811USD | -5,579,118USD | -2,324,000USD |
| Net Income From Continuing Ops | -7,536,598USD | -6,761,316USD | -7,102,455USD | -9,523,835USD | -6,664,371USD | — | -2,161,000USD | -5,265,235USD |
| Ebit | -7,529,899USD | -6,152,565USD | -7,085,923USD | -9,523,835USD | -6,664,371USD | -5,472,976USD | -3,730,228USD | -2,324,000USD |
| Ebitda | -7,506,427USD | -6,130,021USD | -7,064,631USD | -9,510,464USD | -6,650,313USD | -5,455,341USD | -3,701,228USD | -2,307,000USD |
| Depreciation And Amortization | 23,472USD | 22,544USD | 21,292USD | 13,371USD | 14,058USD | 17,635USD | 29,000USD | 17,000USD |
| Reconciled Depreciation | 23,472USD | 22,544USD | 21,292USD | 13,371USD | 14,058USD | — | 17,000USD | 35,627USD |
| Total Other Income Expense Net | -6,699USD | 1,412,041USD | -372,852USD | 352,121USD | 352,652USD | -301,025USD | -1,848,890USD | 61,000USD |
| Unclassified Operating Expenses | — | — | — | — | — | 1,700,681USD | -1,202,541USD | 1,471,340USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD | FY 20202020-06-30 · USD | FY 20192019-06-30 · USD | FY 20182018-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | — | — | — | — |
| Cost Of Revenue | 116,710USD | 55,000USD | 60,000USD | 60,000USD | 32,000USD | 10,000USD | 16,348USD | 24,528USD |
| Gross Profit | -116,710USD | -55,000USD | -60,000USD | -60,000USD | -32,000USD | -10,000USD | -16,348USD | -24,528USD |
| Research Development | 13,335,316USD | 2,663,000USD | 9,311,000USD | 15,173,000USD | 11,815,000USD | 3,630,000USD | 3,662,056USD | 7,132,952USD |
| Selling General Administrative | 4,314,176USD | 4,144,648USD | 2,005,282USD | 2,375,804USD | — | — | — | — |
| Total Operating Expenses | 17,649,492USD | 8,396,000USD | 14,736,000USD | 22,622,000USD | 21,540,000USD | 8,134,000USD | 8,382,147USD | 11,150,135USD |
| Operating Income | -17,649,492USD | -8,451,000USD | -14,796,000USD | -22,682,000USD | -21,572,000USD | -8,144,000USD | -8,398,496USD | -11,174,663USD |
| Interest Income | 361,632USD | 89,673USD | 57,351USD | 0USD | — | — | — | — |
| Interest Expense | 4,138,301USD | 18,688USD | 0USD | 629,286USD | 120,000USD | — | — | — |
| Net Interest Income | -3,776,669USD | 70,985USD | 57,351USD | -629,286USD | — | — | — | — |
| Income Before Tax | -21,682,306USD | -8,320,000USD | -14,649,000USD | -22,661,000USD | -38,298,000USD | -9,126,000USD | -8,048,221USD | -11,138,312USD |
| Net Income | -21,682,306USD | -8,320,000USD | -14,649,000USD | -22,661,000USD | -38,298,000USD | -9,126,000USD | -8,048,221USD | -11,138,312USD |
| Net Income From Continuing Ops | -21,682,306USD | -29,316,826USD | -9,367,513USD | -7,016,509USD | — | — | — | — |
| Ebit | -17,544,005USD | -8,320,000USD | -14,796,000USD | -22,682,000USD | -38,178,000USD | -9,126,000USD | -8,048,218USD | -11,138,309USD |
| Ebitda | -17,427,295USD | -8,265,000USD | -14,736,000USD | -22,622,000USD | -38,146,000USD | -9,116,000USD | -8,031,870USD | -11,113,781USD |
| Depreciation And Amortization | 116,710USD | 55,000USD | 60,000USD | 60,000USD | 32,000USD | 10,000USD | 16,348USD | 24,528USD |
| Reconciled Depreciation | 116,710USD | 177,377USD | 373,093USD | 380,694USD | — | — | — | — |
| Total Other Income Expense Net | -4,032,814USD | 131,000USD | 147,000USD | 21,000USD | -16,726,000USD | -982,000USD | 350,275USD | 36,351USD |
| Unclassified Operating Expenses | — | 1,588,352USD | 3,419,718USD | 5,073,196USD | 9,725,000USD | 4,504,000USD | 4,720,091USD | 4,017,183USD |
| Income Tax Expense | — | -1USD | — | — | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q3 20262026-03-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 31,746,253USD | 29,704,779USD | 25,697,048USD | 34,621,304USD | 14,638,677USD | 19,966,684USD | 4,140,000USD | 6,202,000USD |
| Cash And Equivalents | 995,977USD | — | — | — | — | — | — | — |
| Total Current Assets | 1,655,866USD | 6,982,283USD | 3,503,845USD | 12,539,459USD | 14,325,380USD | 19,610,389USD | 3,483,000USD | 5,528,000USD |
| Other Current Assets | 659,889USD | 684,156USD | 591,730USD | 1,029,088USD | 8,009,996USD | 6,515,810USD | 205,000USD | 619,000USD |
| Other Non Current Assets | 33,754USD | — | — | — | — | — | — | — |
| Total Liabilities | 13,245,793USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 9,255,026USD | 6,066,904USD | 8,834,104USD | 15,171,776USD | 4,782,214USD | 5,330,010USD | 5,429,044USD | 2,259,000USD |
| Other Current Liabilities | 750,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 18,500,460USD | 23,189,881USD | 16,777,959USD | 19,449,528USD | 9,856,463USD | 14,593,976USD | 1,695,000USD | 3,757,000USD |
| Total Equity Including Noncontrolling Interest | 18,500,460USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 745,668USD | 675,645USD | 378,039USD | 144,171USD | 313,297USD | 322,526USD | 657,000USD | 674,000USD |
| Goodwill | 10,738,082USD | — | — | — | — | — | — | — |
| Accounts Payable | 3,076,009USD | 3,954,204USD | 4,127,968USD | 3,646,806USD | 3,084,059USD | 3,152,816USD | 1,282,680USD | 2,207,000USD |
| Short Term Debt | 214,175USD | 206,851USD | 577,732USD | 558,969USD | 164,594USD | 159,844USD | — | — |
| Common Stock | 63,682USD | 63,577USD | 51,255USD | 49,913USD | 43,680USD | 42,324USD | 7,637USD | 55,000USD |
| Retained Earnings | -157,948,976USD | -148,723,589USD | -134,421,497USD | -127,316,953USD | -117,791,029USD | -111,124,569USD | -162,052,000USD | -159,876,000USD |
| Intangible Assets | — | 11,275,000USD | 8,261,000USD | 8,261,000USD | — | — | — | — |
| Total Liab | — | 6,514,898USD | 8,919,089USD | 15,171,776USD | 4,782,214USD | 5,372,708USD | 2,445,000USD | 2,445,000USD |
| Other Current Liab | — | 1,905,849USD | 4,128,404USD | 14,612,807USD | 1,533,561USD | 2,017,350USD | 4,146,364USD | 52,000USD |
| Capital Stock | — | 342,108USD | 329,785USD | 328,443USD | 322,210USD | — | 281,000USD | — |
| Good Will | — | 10,738,082USD | 13,554,164USD | 13,554,163USD | — | — | — | — |
| Cash | — | 6,298,127USD | 2,697,416USD | 8,512,824USD | 6,219,831USD | 12,657,178USD | 3,020,000USD | 4,909,000USD |
| Cash And Short Term Investments | — | 6,298,127USD | 2,697,416USD | 8,512,824USD | 6,219,831USD | 12,657,178USD | 3,020,000USD | 4,909,000USD |
| Net Debt | — | -5,841,201USD | -2,119,684USD | -7,953,855USD | -6,055,237USD | -12,454,636USD | -3,020,000USD | -4,909,000USD |
| Short Long Term Debt Total | — | 456,926USD | 577,732USD | 558,969USD | 164,594USD | 202,542USD | — | — |
| Property Plant Equipment Gross | — | 2,857,830USD | 2,514,207USD | 2,381,558USD | 2,414,802USD | — | 657,000USD | — |
| Common Stock Shares Outstanding | — | 60,010,237shares | 50,666,430shares | 44,555,095shares | 43,404,947shares | 42,323,759shares | 2,181,906shares | 1,580,142shares |
| Non Current Assets Total | — | 22,722,496USD | 22,193,203USD | 21,959,334USD | 313,297USD | 356,295USD | 657,000USD | 674,000USD |
| Non Current Liabilities Total | — | 447,993USD | 84,985USD | 0USD | 0USD | 42,698USD | 24,451,159USD | 186,000USD |
| Non Currrent Assets Other | — | 33,769USD | — | — | — | 33,769USD | — | — |
| Net Working Capital | — | 915,379USD | -5,330,259USD | -2,632,317USD | 9,543,166USD | — | 1,226,000USD | — |
| Unclassified Equity | — | 171,507,785USD | 150,818,416USD | 146,388,125USD | 130,339,506USD | 125,676,221USD | 163,437,363USD | 163,557,000USD |
| Short Long Term Debt | — | — | 493,386USD | 434,000USD | — | — | — | — |
| Net Receivables | — | — | 214,699USD | 2,997,547USD | 95,553USD | 222,702USD | 258,000USD | — |
| Non Current Liabilities Other | — | — | 84,985USD | — | — | — | 188,000USD | — |
| Unclassified Current Liabilities | — | — | — | -4,080,806USD | — | — | — | — |
| Accumulated Other Comprehensive Income | — | — | — | — | -3,057,904USD | — | 21,000USD | 21,000USD |
| Other Assets | — | — | — | — | — | 1USD | — | — |
| Short Term Investments | — | — | — | — | — | 5,994,503USD | — | — |
| Inventory | — | — | — | — | — | 214,699USD | — | — |
| Unclassified Current Assets | — | — | — | — | — | -5,994,503USD | — | — |
| Unclassified Non Current Liabilities | — | — | — | — | — | — | 24,263,159USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD | FY 20202020-06-30 · USD | FY 20192019-06-30 · USD | FY 20182018-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 19,966,684USD | 4,361,791USD | 15,196,608USD | 6,402,223USD | 13,543,000USD | 2,938,000USD | 4,037,255USD | 7,074,855USD |
| Other Current Assets | 6,515,810USD | 159,326USD | 390,350USD | 135,128USD | 1,256,000USD | 365,000USD | 280,248USD | 1,034,930USD |
| Total Liab | 5,372,708USD | 5,920,537USD | 2,892,667USD | 7,150,044USD | 2,962,000USD | 2,675,000USD | 2,069,725USD | 1,639,632USD |
| Total Stockholder Equity | 14,593,976USD | -1,558,746USD | 12,303,941USD | -747,821USD | 10,581,000USD | 263,000USD | 1,967,530USD | 5,435,223USD |
| Other Current Liab | 2,017,350USD | 1,708,797USD | 838,677USD | 6,092,180USD | 561,000USD | 664,000USD | 325,208USD | 160,429USD |
| Common Stock | 42,324USD | 6,801USD | 4,529USD | 4,529USD | 33,000USD | 11,000USD | 3,839USD | 22,967USD |
| Capital Stock | 320,854USD | 14,857USD | 12,591USD | 9,227USD | — | — | — | — |
| Retained Earnings | -111,124,569USD | -88,474,997USD | -59,158,171USD | -49,479,368USD | -111,225,000USD | -69,721,000USD | -60,578,345USD | -52,441,337USD |
| Good Will | 0USD | — | — | — | — | — | — | — |
| Cash | 12,657,178USD | 3,665,032USD | 14,252,518USD | 5,546,054USD | 10,537,000USD | 2,392,000USD | 3,718,758USD | 5,971,995USD |
| Cash And Short Term Investments | 12,657,178USD | 3,665,032USD | 14,252,518USD | 5,546,054USD | 10,537,000USD | 2,392,000USD | 3,718,758USD | 5,971,995USD |
| Total Current Assets | 19,610,389USD | 4,158,801USD | 14,744,292USD | 5,681,182USD | 11,793,000USD | 2,757,000USD | 4,025,193USD | 7,046,444USD |
| Total Current Liabilities | 5,330,010USD | 3,596,379USD | 2,871,924USD | 7,150,044USD | 2,780,000USD | 2,675,000USD | 2,069,725USD | 1,638,515USD |
| Net Debt | -12,454,636USD | -1,320,054USD | -14,114,294USD | -4,901,984USD | -10,537,000USD | -2,392,000USD | -3,718,758USD | -5,971,995USD |
| Short Term Debt | 159,844USD | 20,820USD | 117,481USD | 644,070USD | — | — | — | — |
| Short Long Term Debt Total | 202,542USD | 2,344,978USD | 138,224USD | 644,070USD | — | — | — | — |
| Net Receivables | 222,702USD | 334,443USD | 101,424USD | — | — | — | 26,187USD | 39,519USD |
| Inventory | 214,699USD | — | — | — | — | — | — | — |
| Accounts Payable | 3,152,816USD | 1,866,762USD | 1,915,766USD | 413,794USD | 2,219,000USD | 2,011,000USD | 1,744,517USD | 1,478,086USD |
| Property Plant Equipment Net | 322,526USD | 202,990USD | 418,547USD | 617,139USD | 150,000USD | 2,000USD | — | — |
| Property Plant Equipment Gross | 2,409,973USD | 2,173,726USD | 2,211,906USD | 2,037,405USD | — | — | — | — |
| Common Stock Shares Outstanding | 18,662,690shares | 752,914shares | 46,285shares | 27,829shares | 14,791shares | 5,968shares | 1,471shares | 1,192shares |
| Non Current Assets Total | 356,295USD | 202,990USD | 452,316USD | 721,041USD | 1,750,000USD | 181,000USD | 12,062USD | 28,411USD |
| Non Current Liabilities Total | 42,698USD | 2,324,158USD | 20,743USD | 0USD | 182,000USD | — | — | 1,117USD |
| Non Currrent Assets Other | 33,769USD | — | 33,769USD | 103,902USD | 1,600,000USD | 179,000USD | — | — |
| Net Working Capital | 14,280,379USD | 562,422USD | 11,872,368USD | -1,468,862USD | — | — | — | — |
| Unclassified Equity | 125,355,367USD | 86,894,593USD | 71,444,992USD | 48,717,791USD | 121,752,000USD | 69,952,000USD | 55,932,575USD | 49,602,933USD |
| Long Term Debt | — | 2,324,158USD | — | — | — | — | — | — |
| Short Long Term Debt | — | — | — | 644,070USD | — | — | — | — |
| Accumulated Other Comprehensive Income | — | — | — | — | 21,000USD | 21,000USD | 6,609,461USD | 8,250,660USD |
| Intangible Assets | — | — | — | — | — | — | 12,062USD | 28,411USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 51,576USD |
| Stock Based Compensation | 4,939,474USD |
| Change To Liabilities | -1,660,400USD |
| Change In Working Capital | -1,586,636USD |
| Operating Cash Flow | -13,046,552USD |
| Capital Expenditures | -185,824USD |
| Investing Cash Flow | -185,824USD |
| Net Debt Issuance | -21,895USD |
| Unclassified Financing Cash Flow | 10,630,299USD |
| Financing Cash Flow | 10,608,404USD |
| Change In Cash | -2,623,972USD |
| End Cash Flow | 995,977USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -7,536,598USD | -6,761,316USD | -7,102,455USD | -9,523,835USD | -6,664,371USD | -5,995,811USD | -2,161,000USD | -5,265,235USD |
| Depreciation | 23,472USD | 22,544USD | 21,292USD | 13,371USD | 14,058USD | 17,635USD | 29,000USD | 35,627USD |
| Stock Based Compensation | 2,796,240USD | 1,962,448USD | 1,630,499USD | 1,407,047USD | 1,424,736USD | — | 101,000USD | 275,492USD |
| Other Non Cash Items | 2,796,240USD | -1,240,165USD | 315,660USD | — | — | 1,250,702USD | -10,000USD | 420,789USD |
| Change In Working Capital | 303,933USD | 460,467USD | -5,951,540USD | 1,855,255USD | 487,155USD | 2,127,857USD | 152,000USD | -879,574USD |
| Total Cash From Operating Activities | -4,412,953USD | -5,556,022USD | -11,086,544USD | -6,248,162USD | -4,738,422USD | -2,599,617USD | -1,889,000USD | -5,065,808USD |
| Capital Expenditures | -48,847USD | -27,850USD | -4USD | -5,561USD | -42,672USD | -21,403USD | 0USD | 0USD |
| Free Cash Flow | -4,461,800USD | -5,583,872USD | -11,086,544USD | -6,253,723USD | -4,781,094USD | -2,621,020USD | -1,889,000USD | -5,102,306USD |
| Total Cashflows From Investing Activities | -48,846USD | -27,850USD | 823,540USD | -156,464USD | -1,151,047USD | -823,540USD | — | — |
| Net Borrowings | -208,199USD | 1,193,324USD | -576,348USD | 0USD | 0USD | — | — | 14,165,000USD |
| Total Cash From Financing Activities | 7,139,977USD | 6,506,405USD | 5,271,136USD | 8,697,619USD | -547,878USD | -3,515,687USD | 0USD | 12,952,102USD |
| Dividends Paid | -2,089USD | -2,089USD | -2,089USD | -2,089USD | -2,089USD | — | 0USD | 0USD |
| Issuance Of Capital Stock | 7,500,000USD | 6,191,140USD | 6,197,547USD | 5,914,625USD | 0USD | — | — | — |
| Change In Cash | 2,678,178USD | 922,533USD | -5,815,408USD | 2,292,993USD | -6,437,347USD | — | -1,889,000USD | 7,849,796USD |
| Begin Period Cash Flow | 3,619,949USD | 2,697,416USD | 8,512,824USD | 6,219,831USD | 12,657,178USD | 19,596,022USD | 4,909,000USD | 4,461,490USD |
| End Period Cash Flow | 6,298,127USD | 3,619,949USD | 2,697,416USD | 8,512,824USD | 6,219,831USD | 12,657,178USD | 3,020,000USD | 12,311,286USD |
| Other Cashflows From Financing Activities | 7,142,066USD | -875,970USD | -347,974USD | 5,579,084USD | -550,000USD | -4,426,575USD | — | — |
| Unclassified Operating Cash Flow | -2,796,240USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | -7,291,801USD | 6,691,140USD | — | 3,620,624USD | — | — | — | -1,212,898USD |
| Sale Purchase Of Stock | — | -500,000USD | — | -500,000USD | — | — | — | — |
| Other Cashflows From Investing Activities | — | 2,088,379USD | — | -150,903USD | — | — | — | — |
| Unclassified Investing Cash Flow | — | -2,088,379USD | — | — | — | — | — | — |
| Investments | — | — | 0USD | -156,464USD | -1,151,047USD | — | — | -36,498USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD | FY 20202020-06-30 · USD | FY 20192019-06-30 · USD | FY 20182018-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -21,682,306USD | -29,316,826USD | -9,367,513USD | -7,016,509USD | -38,298,000USD | -9,126,000USD | -8,048,221USD | -11,138,312USD |
| Depreciation | 116,710USD | 177,377USD | 373,093USD | 380,694USD | 32,000USD | 10,000USD | 16,348USD | 24,528USD |
| Stock Based Compensation | 1,958,663USD | 478,890USD | 218,275USD | 654,529USD | — | — | — | — |
| Other Non Cash Items | 1,592,196USD | 20,997,635USD | -294,070USD | -527,057USD | 22,057,000USD | 701,000USD | 569,655USD | 685,420USD |
| Change In Working Capital | 3,286,599USD | 486,924USD | 1,561,956USD | -55,000USD | -2,651,000USD | 487,000USD | 1,134,793USD | 577,514USD |
| Total Cash From Operating Activities | -14,728,138USD | -7,176,000USD | -7,508,259USD | -6,563,343USD | -18,860,000USD | -7,928,000USD | -6,327,425USD | -9,850,850USD |
| Capital Expenditures | -57,906USD | -79,224USD | -232,000USD | -3,280USD | -8,000USD | 0USD | -5USD | -9,850,850USD |
| Free Cash Flow | -14,786,044USD | -12,030,080USD | -7,544,536USD | -6,566,623USD | -18,868,000USD | -7,928,000USD | -6,327,420USD | — |
| Investments | -6,052,409USD | -1,296,879USD | -36,277USD | -3,280USD | — | — | — | — |
| Total Cashflows From Investing Activities | -6,052,409USD | -1,296,879USD | -36,277USD | -3,280USD | 964,000USD | — | — | -12,649USD |
| Net Borrowings | 28,568,000USD | 2,685,000USD | -350,000USD | 294,070USD | — | — | — | — |
| Total Cash From Financing Activities | 29,772,693USD | 2,660,249USD | 16,251,000USD | 7,044,536USD | 26,041,000USD | 6,601,000USD | 4,074,188USD | 9,249,480USD |
| Dividends Paid | 0USD | — | — | -8,000USD | -8,000USD | -8,000USD | -8,356USD | -8,356USD |
| Sale Purchase Of Stock | 0USD | -24,751USD | 0USD | — | — | — | — | — |
| Issuance Of Capital Stock | 5,000,000USD | 0USD | 16,601,000USD | 6,750,466USD | — | — | — | — |
| Change In Cash | 8,992,146USD | -10,587,486USD | 8,706,464USD | 477,913USD | — | — | — | — |
| Begin Period Cash Flow | 3,665,032USD | 14,252,518USD | 5,546,054USD | 5,068,141USD | 2,392,000USD | 3,718,758USD | 5,971,995USD | 6,586,014USD |
| End Period Cash Flow | 12,657,178USD | 3,665,032USD | 14,252,518USD | 5,546,054USD | 10,537,000USD | 2,392,000USD | 3,718,758USD | 5,971,995USD |
| Other Cashflows From Financing Activities | -3,795,307USD | 24,726USD | 16,601,000USD | 1,158,466USD | -30,000USD | -25,000USD | — | — |
| Unclassified Financing Cash Flow | 5,000,000USD | — | — | -1,150,466USD | 26,079,000USD | 6,634,000USD | 4,082,544USD | 9,257,836USD |
| Change To Account Receivables | — | — | — | — | — | 16,786USD | 13,332USD | 37,076USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | — | 9,838,201USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.